HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dc07-1898v1 31/3/397    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fukui, M. Articles by Nakamura, N. Search for Related Content PubMed PubMed Citation Articles by Fukui, M. Articles by Nakamura, N. Social Bookmarking                What's this?

Association Between Serum Bioavailable Testosterone Concentration and the Ratio of Glycated Albumin to Glycated Hemoglobin in Men With Type 2 Diabetes

¹ Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan
² Department of Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

Address correspondence and reprint requests to Michiaki Fukui, MD, Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. E-mail: sayarinapm{at}hotmail.com

OBJECTIVE—Testosterone stimulates erythropoiesis and thus glycated hemoglobin (A1C) values may be relatively low in male diabetic patients with hypogonadism. We therefore investigated relationships between serum bioavailable testosterone concentration and the ratio of glycated albumin (GA) to A1C and between serum bioavailable testosterone and hemoglobin concentrations in men with type 2 diabetes.

RESEARCH DESIGN AND METHODS—The above relationships were investigated in 222 consecutive men with type 2 diabetes. We also investigated how the ratio of GA to A1C is related to other variables such as age, BMI, and degree of diabetic microangiopathy.

RESULTS—Mean ratio of GA to A1C was 2.94 ± 0.38. Serum bioavailable testosterone concentration correlated positively with hemoglobin concentration (r = 0.368, P < 0.0001) and negatively with the ratio of GA to A1C (r = –0.278, P < 0.0001). Multiple regression analyses identified serum bioavailable testosterone concentration (β = 0.187, P = 0.0062), age (β = –0.204, P = 0.0075), BMI (β = 0.151, P = 0.0302), systolic blood pressure (β = 0.173, P = 0.0090), and plasma total cholesterol (β = 0.155, P = 0.0141) as independent determinants of hemoglobin concentration; moreover, serum bioavailable testosterone concentration (β = –0.155, P = 0.0381) and plasma total cholesterol (β = –0.170, P = 0.0144) were identified as independent determinants of the ratio of GA to A1C.

CONCLUSIONS—Serum bioavailable testosterone concentration correlated positively with hemoglobin concentration and negatively with the ratio of GA to A1C in men with type 2 diabetes, which may lead to underestimation of A1C in hypogonadal men with type 2 diabetes.

Abbreviations: CVD, cardiovascular disease • GA, glycated albumin

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?